IO Biotech has been granted an Industrial PhD project entitled 'Characterisation of a PD-L1-based cancer vaccine in vivo' from Innovation Fund Denmark. The Industrial PhD will be performed in collaboration with Department of Immunology and Microbiology, University of Copenhagen, between June 2016 and June 2019.
IO Biotech is pleased to be invited to present at Bio€quity Europe, which this year is venued in Copenhagen. This is a much welcomed chance to elaborate on the company's scentific findings and current research to the financial community and international business development professionals.
Copenhagen, Denmark - January 5, 2016: IO Biotech today announced the successful completion of a €11 million Series A financing round. Participants were new investor Lundbeckfonden as well as existing investor Novo A/S.